Position in ASND
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$4,240,848
-$355,481 QoQ
Shares Held
15,900
-20.9% QoQ
Ownership
0.024%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#127
of 308 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ASND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SIT INVESTMENT ASSOCIATES INC holds $12,820,881 across 7 Biotechnology names. ASND ranks #1 (33.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
This page
|
15,900 | $4,240,848 | |
| 2 | VCEL |
Vericel Corp
|
83,185 | $3,700,900 | |
| 3 | TECH |
BIO-TECHNE Corp
|
31,875 | $2,251,968 | |
| 4 | TGTX |
Tg Therapeutics, Inc.
|
20,480 | $1,125,171 | |
| 5 | ARQT |
Arcutis Biotherapeutics, Inc.
|
28,900 | $757,758 | |
| 6 | SPRY |
ARS Pharmaceuticals, Inc.
|
92,875 | $743,928 | |
| 7 | MREO |
Mereo BioPharma Group plc
|
970 | $308 |
All Filings in ASND
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,240,848 | 15,900 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $4,596,329 | 20,095 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $4,285,057 | 20,095 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $3,995,086 | 20,095 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $3,349,303 | 19,405 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,024,463 | 19,405 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $2,671,486 | 19,405 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $2,897,360 | 19,405 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,756,574 | 12,880 | Shares | Sole | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||